iDOVE

Durability of Vaccine Efficacy Against SARS-CoV-2 Infection

Shannon T. Holloway, Yu Gu, Dan-Yu Lin

Last update: 13 December 2023

Copyright license: GNU General Public License, version 2.0

Software version identifier: 1.4, 1.3, 1.5

Description

Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) <doi:10.1093/cid/ciab630>.

Cites work

Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection

This page was built for software: iDOVE